Molecular Biomarkers in Cancer

Molecular cancer biomarkers are any measurable molecular indicator of risk of cancer, occurrence of cancer, or patient outcome. They may include somatic genetic variants, epigenetic signatures, transcriptional changes and proteomic signatures. These indicators are based on biomolecules, such as nucleic acids and proteins, that can be detected in samples obtained from tissues through tumor biopsy or, more easily and non-invasively, from blood, saliva.

  • Biomolecules
  • Detection technologies
  • Clinical applications of biomarkers
  • Diagnosis and prognosis of Cancer
  • Cancer Medicine

Related Conference of Molecular Biomarkers in Cancer

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Molecular Biomarkers in Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in